These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31904094)

  • 1. A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer.
    Shimura T; Toden S; Komarova NL; Boland C; Wodarz D; Goel A
    Carcinogenesis; 2020 Jul; 41(6):751-760. PubMed ID: 31904094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.
    Zumwalt TJ; Wodarz D; Komarova NL; Toden S; Turner J; Cardenas J; Burn J; Chan AT; Boland CR; Goel A
    Cancer Prev Res (Phila); 2017 Mar; 10(3):208-218. PubMed ID: 28154202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.
    Rohwer N; Kühl AA; Ostermann AI; Hartung NM; Schebb NH; Zopf D; McDonald FM; Weylandt KH
    Cancer Med; 2020 Apr; 9(7):2535-2550. PubMed ID: 31994315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.
    Chen Z; Wang C; Dong H; Wang X; Gao F; Zhang S; Zhang X
    Mol Med; 2020 Jan; 26(1):14. PubMed ID: 32000660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin's effect on kinetic parameters of cells contributes to its role in reducing incidence of advanced colorectal adenomas, shown by a multiscale computational study.
    Wang Y; Boland CR; Goel A; Wodarz D; Komarova NL
    Elife; 2022 Apr; 11():. PubMed ID: 35416770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
    Lu S; Obianom ON; Ai Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo.
    Claudius AK; Kankipati CS; Kilari RS; Hassan S; Guest K; Russell ST; Perry CJ; Stark LA; Nicholl ID
    Oncol Rep; 2014 Oct; 32(4):1670-80. PubMed ID: 25109257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as a chemoprevention agent for colorectal cancer.
    Lee CS; McNamara D; O'Morain CA
    Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.
    Zhu Y; Yang C; Weng M; Zhang Y; Yang C; Jin Y; Yang W; He Y; Wu Y; Zhang Y; Wang G; RajkumarEzakiel Redpath RJ; Zhang L; Jin X; Liu Y; Sun Y; Ning N; Qiao Y; Zhang F; Li Z; Wang T; Zhang Y; Li X
    Oncotarget; 2017 Apr; 8(14):22759-22771. PubMed ID: 28184026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
    Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
    PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer].
    Wang HJ; Peng ZL; Liu XQ; Yang KX; Lou JY; Luo FM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):428-32. PubMed ID: 17593823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.
    Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH; Ju YC; Wang MX; Li ZX
    Curr Cancer Drug Targets; 2018; 18(3):278-286. PubMed ID: 28359236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells.
    Suman S; Das TP; Sirimulla S; Alatassi H; Ankem MK; Damodaran C
    Oncotarget; 2016 Mar; 7(12):13854-64. PubMed ID: 26883103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.
    Henry WS; Laszewski T; Tsang T; Beca F; Beck AH; McAllister SS; Toker A
    Cancer Res; 2017 Feb; 77(3):790-801. PubMed ID: 27940576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.
    Mikami J; Kurokawa Y; Takahashi T; Miyazaki Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2016 Jul; 19(3):817-26. PubMed ID: 26486505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin on tumour cell colony formation and evolution.
    Wodarz D; Goel A; Boland CR; Komarova NL
    J R Soc Interface; 2017 Sep; 14(134):. PubMed ID: 28878032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo.
    Piazuelo E; Esquivias P; De Martino A; Cebrián C; Conde B; Santander S; Emperador S; García-González MA; Carrera-Lasfuentes P; Lanas A
    Dig Dis Sci; 2016 Oct; 61(10):2896-2907. PubMed ID: 27343037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.